IPO

Tarsons Products Limited IPO

Mainboard

Plastic Products

Listed On: Nov 26, 2021 at ₹ 682 (NSE)

₹ 14564 /22 Shares

Check Allotment

15 Nov, 2021

Open Date

17 Nov, 2021

Close Date

23 Nov, 2021

Allotment Date

26 Nov, 2021

Listing Date
Price Summary

Last Closing

229.70 (-65.3%)

52 Week High

458.00

52 Week Low

198.00

Last Update

19-Dec-2025 3:30 PM
IPO Issue Details
  • Issue Price ₹635-662 per equity share
  • Face Value ₹2 Per Equity Share 
  • Issue Price Total 1023.47 Crores : 150 Crores Fresh Issue + 873.84 Crores Approx Offer for Sale
  • Listing at BSE, NSE
  • List Price 682 (NSE)
  • Listing Date 2021-11-26
  • Lead Manager Edelweiss Financial Services Ltd, ICICI Securities Limited, SBI Capital Markets Limited
  • Registrar KFintech Private Limited
IPO Details
  • Retail Portion 35% (Number of Retail Applications : 2,45,000 Approx)
IPO Documents
DRHP
RHP
IPO Details


The IPO of is priced at ₹635-662 per equity share, which has a face value of ₹2 Per Equity Share  each, IPO bidding starts from Nov 15, 2021 and ends on Nov 17, 2021. The allotment for IPO will be finalized on Nov 23, 2021. IPO will be listed on BSE, NSE, with a tentative listing date fixed as Nov 26, 2021. The company shall list its equity shares on the BSE, NSE. KFintech Private Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are Edelweiss Financial Services Ltd, ICICI Securities Limited, SBI Capital Markets Limited.


The IPO sets its price band at 635-662 for each share. A single application for Tarsons Products Limited IPO must contain at least 22 shares.

Read More
IPO Subscription Analysis And Details
Retail
10.55x
QIB
115.77x
NII
184.58x
Total
77.49x
As on QIB NII Retail Total
Shares Offered / Reserved 30,81,172 23,10,880 53,92,052 108,44,104
Day 1 15-11-21 05:00 PM
0.00 x 0.07 2.12 x 1.10 x
Day 2 16-11-21 05:00 PM
1.30 x 3.98 4.74 x 3.58 x
Day 3 17-11-21 05:00 PM
115.77 x 184.58 10.55 x 77.49 x
Total No of Applications
2222778
Subscription on the basis of Applications
9.07
Valuations
Earnings Per Share (EPS) ₹12.94/-
P/E Ratio 51.14
RoNW 28.19%
Net Asset Value (NAV) - As on 30.06.21 ₹52.80
Company Financials
In Crs.
In Cr.
31-Mar-21 31-Mar-20 31-Mar-19
Assets 295.95 248.70 211.95
Revenue 234.29 180.05 184.71
Profit After Tax 68.87 40.53 38.95
About Company

Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products. The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company's product portfolio is classified into three broad categories including consumables, reusables, and others. As of March 31, 2021, the company has a diversified product portfolio with over 1,700 SKUs across 300 products.Trason's products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals. The company has many reputed institutes, medical labs, and hospitals as its key clients.Currently, the company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.

Read More
- Promoter(s)

Sanjive Sehgal

Rohan Sehgal

Pre Issue Share Holding : N/A%

Post Issue Share Holding : N/A%

IPO - Issue Objectives
1

Repayment/prepayment of all or certain of company’s borrowings;

2

Funding a part of the capital expenditure for new manufacturing facility at Panchla, West Bengal (proposed expansion) and;

3

General corporate purposes

IPO - Anchor Investors

Tarsons Products mops up Rs 305.96 crore from anchor investors ahead of listing

Foreign investors who participated in the anchor book were Monetary Authority of Singapore, Government of Singapore, First Sentier Investors, Pinebridge Global Funds, Abu Dhabi Investment Authority, Theleme India Master Fund, and East Bridge Capital.

ICICI Prudential, Aditya Birla Sun Life, Nippon Life, Sundaram Mutual Fund, L&T Mutual Fund, Edelweiss Trusteeship and Reliance General Insurance among domestic investors who invested in the company.